PRESS RELEASE published on 10/30/2025 at 21:30, 4 months 22 days ago DBV Technologies annonce la nomination de Philina Lee, Ph.D. au sein de son Conseil d’administration DBV Technologies nomme Philina Lee, Ph.D. au Conseil d’administration et Comité des rémunérations. Lee apporte son expertise en biopharmaceutique et commercialisation. DBV se concentre sur le traitement des allergies alimentaires Conseil D'administration Biopharmaceutique DBV Technologies Allergies Alimentaires Philina Lee
PRESS RELEASE published on 10/30/2025 at 21:30, 4 months 22 days ago DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors DBV Technologies appoints Dr. Philina Lee, Ph.D. as independent director to Board of Directors, bringing extensive biopharmaceutical experience. Company focused on VIASKIN® Peanut for food allergies Board Of Directors DBV Technologies Food Allergies Viaskin Peanut Dr. Philina Lee
BRIEF published on 10/28/2025 at 21:30, 4 months 24 days ago DBV Technologies Announces Q3 2025 Financial Results Financial Results Treasury Funding Net Loss Viaskin Peanut
BRIEF published on 10/28/2025 at 21:30, 4 months 24 days ago DBV Technologies annonce ses résultats financiers du T3 2025 Résultats Financiers Financement Trésorerie Perte Nette Viaskin Peanut
PRESS RELEASE published on 10/28/2025 at 21:25, 4 months 24 days ago DBV Technologies Reports Third Quarter 2025 Financial Results DBV Technologies reports Q3 2025 financial results with a cash balance of $69.8M, projecting cash runway into Q3 2026. Details on operating income, expenses, net loss, cash flow, and funding activities Financial Results Cash Balance DBV Technologies Funding Activities Q3 2025
PRESS RELEASE published on 10/28/2025 at 21:25, 4 months 24 days ago DBV Technologies publie ses résultats financiers du troisième trimestre 2025 DBV Technologies publie les résultats financiers du troisième trimestre 2025, affichant une trésorerie de 69,8 millions de dollars, soutenant les activités jusqu'au T3 2026 Résultats Financiers Trésorerie États Financiers DBV Technologies U.S. GAAP
BRIEF published on 10/14/2025 at 15:49, 5 months 8 days ago Change of Participation at DBV Technologies Capital Increase Threshold Crossing DBV Technologies Invus Public Equities Contracts For Differences
BRIEF published on 10/14/2025 at 15:49, 5 months 8 days ago Changement de Participation chez DBV Technologies Franchissement De Seuil Augmentation De Capital DBV Technologies Invus Public Equities Contracts For Differences
PRESS RELEASE published on 10/14/2025 at 15:44, 5 months 8 days ago Franchissement de seuils Déclaration de franchissement de seuils par Invus Public Equities pour DBV TECHNOLOGIES suite à une souscription à une augmentation de capital Augmentation De Capital Franchissement De Seuils Souscription DBV Technologies Invus Public Equities
BRIEF published on 10/06/2025 at 23:07, 5 months 15 days ago DBV Technologies lève 30 millions de dollars grâce au programme ATM du Nasdaq Nasdaq Augmentation De Capital DBV Technologies Programme ATM Vente D'annonces
Published on 03/20/2026 at 13:30, 2 days 5 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 6 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/22/2026 at 12:23, 6 hours 10 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 1 day 19 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 21 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 21 hours ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 19:00, 1 day 23 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 23 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
